Bart De Vree
YOU?
Author Swipe
View article: Menopausal symptoms after hysterectomy with opportunistic salpingectomy: a pilot study
Menopausal symptoms after hysterectomy with opportunistic salpingectomy: a pilot study Open
The development of subjective menopausal symptoms is evaluated after hysterectomy with opportunistic salpingectomy.
View article: Laparoscopic niche repair: A small retrospective multicenter study
Laparoscopic niche repair: A small retrospective multicenter study Open
The aim of this study was to evaluate laparoscopic niche repair as a safe and therapeutical option for patients with a residual myometrial thickness (RMT) ≤ 3 mm. This was a retrospective multicenter study of all patients undergoing a lapa…
View article: Survey: acceptability of opportunistic bilateral salpingectomy in Flanders
Survey: acceptability of opportunistic bilateral salpingectomy in Flanders Open
Background: The VVOG (Flemish Society of Obstetrics and Gynaecology) published a consensus statement promoting opportunistic bilateral salpingectomy (OBS). Objectives: The aim of the study was to obtain insight into the current opinion and…
View article: Prospective International Multicenter Pelvic Floor Study: Short-Term Follow-Up and Clinical Findings for Combined Pectopexy and Native Tissue Repair
Prospective International Multicenter Pelvic Floor Study: Short-Term Follow-Up and Clinical Findings for Combined Pectopexy and Native Tissue Repair Open
Efforts to use traditional native tissue strategies and reduce the use of meshes have been made in several countries. Combining native tissue repair with sufficient mesh applied apical repair might provide a means of effective treatment. T…
View article: Effect on surgical decisions: Ulipristal acetate as key player in Belgian phase <scp>IV</scp> registration trial
Effect on surgical decisions: Ulipristal acetate as key player in Belgian phase <span>IV</span> registration trial Open
Objective To observe alterations in surgical planning that were due to the use of ulipristal acetate ( UPA ) 5 mg daily for symptomatic uterine fibroids. Methods A prospective cohort trial involving women with symptomatic fibroids was unde…